UTI PROx

Complex and chronic urinary tract infections (UTIs) are a serious threat that impacts antibiotic stewardship, the risk for hospitalization, and overall patient health, especially in those with multiple comorbidities.

The UTI PROx panel is the only combination panel that combines culture and antimicrobial susceptibility testing with molecular (PCR) identification techniques, providing unparalleled and comprehensive advantages in speed and accuracy to help guide personalized treatment decisions.

UTI PROx Features
  • Combined molecular and culture sample analysis, including antimicrobial susceptibility
  • Detects 34 bacterial and fungal pathogens, including polymicrobial infections
  • PCR results available within 24 hours of lab receipt
  • Comprehensive final report available within 48-72 hours of lab receipt
  • Screens for 18 antibiotic resistance genes

Rapid detection of polymicrobial infections and antibiotic resistance genes

FAQ

For healthcare providers:
If this is your first time ordering from AccessDx Laboratory, please complete our New Account Form, and we will contact you to schedule your client onboarding.

Once your onboarding is complete, we will send you instructions for logging in to the AccessDx Provider Portal for test ordering and results review, or you can complete and return the UTI PROx Test Requisition Form included with your test kits.

If you are a current AccessDx Laboratory client, please contact our customer service team at [email protected] and provide the number of kits requested and the address where the kits should be delivered.

If you are not a current AccessDx Laboratory client, contact [email protected].

UTI PROx analyzes 34 bacterial and fungal pathogens:

Bacteria: Acinetobacter baumannii, Actinotignum schaalii, Aerococcus urinae, Alloscardovia omnicolens, Citrobacter freundii, Citrobacter koseri, Coagulase-negative Staphylococci, Corynebacterium riegelii, Enterobacter aerogenes, Enterobacter cloacae, Enterococcus faecalis, Enterococcus faecium, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Mycoplasma genitalium, Mycoplasma hominis, Pantoea agglomerans, Proteus mirabilis, Proteus vulgaris, Providencia stuartii, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus spp., Streptococcus agalactiae, Ureaplasma spp., Viridans group Streptococci.

Fungi: Candida albicans, Candida auris, Candida glabrata, Candida krusei, Candida parasilosis, Candida tropicalis

UTI PROx analyzes many antibiotic resistance genes: ampC; IMP-1 group, IMP-16, IMP-7; OXA-23, OXA-72, OXA-40, blaOXA-48; VIM; CTX-M group 1, CTX-M group 2, CTX-M group 9, CTX-M group 8/25; OXA-1, GES; PER-1, PER-2; TEM; mecA; QnrA, QnrS, Qnr B; vanA1, vanA2, vanB; dfrA5, dfrA1; Sul1, Sul2; FOX; ACC; SHV; VEB; KPC

For additional questions, please contact us at [email protected].

PCR test results are typically available within 24 hours of lab receipt, with a comprehensive final report available within 48-72 hours of lab receipt.

AccessDx Laboratory is certified by CLIA, CAP, and NYSDOH.

UTI PROx was designed to:

  • Adhere to industry guidelines and recommendations
  • Quickly provide initial molecular results within 24 hours of lab receipt
  • Combines molecular and culture-based results to affirm therapeutic effectiveness

AccessDx offers patient pay, insurance, and institutional billing options.

For questions about billing, please contact [email protected].

Please refer to the UTI PROx Collection Instructions, available here.

A sample UTI PROx report can be provided upon request by contacting  [email protected].

 

UTI PROx ordering availability is subject to client onboarding. Please contact your AccessDx Laboratory representative to learn more.